Literature DB >> 2460193

Kinetics and distribution volumes for tracers of different sizes in the brain plasma space.

Q R Smith1, Y Z Ziylan, P J Robinson, S I Rapoport.   

Abstract

Regional brain and plasma concentrations were determined for a series of radiotracers that differ in molecular weight and size in pentobarbital-anesthetized rats at 1, 5 and 30 min after i.v. injection. The tracers, [3H]inulin (mol. wt. 5000 Da, radius 1.5 nm), 5 [3H]dextrans (10,000-200,000 Da, 2.3-9.5 nm) and [51Cr]transferrin (79,000 Da, 3.8 nm), are not taken up into erythrocytes and do not measurably cross the blood-brain barrier in 30 min. Results were expressed as a brain distribution volume, defined as (dpm/g brain)/(dpm/ml plasma). Within 1 min after injection, all tracers attained an initial distribution volume which varied regionally from 0.4 to 1.6 X 10(-2) ml/g. The volumes remained constant between 1 and 30 min for tracers with radii greater than or equal to 3.8 nm, whereas the volumes increased up to 90% for tracers with radii less than or equal to 3.1 nm. Rates of equilibration for tracers with radii less than or equal to 3.1 nm were size dependent with smaller tracers equilibrating before larger tracers. These results indicate that the brain distribution volume for plasma tracers consists of two compartments: one which is quickly filled (less than or equal to 1 min) by all tracers and comprises approximately 60% of the total volume, and one which allows only tracers with radii less than or equal to 3.1 nm and comprises 40% of the total volume. The inverse relation between the rate of equilibration in the second compartment and molecular size may indicate a diffusion limitation.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2460193     DOI: 10.1016/0006-8993(88)90577-x

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  10 in total

1.  Effects of hepatic ischemia-reperfusion injury on the blood-brain barrier permeability to [14C] and [13C]sucrose.

Authors:  Mohammad K Miah; Ulrich Bickel; Reza Mehvar
Journal:  Metab Brain Dis       Date:  2017-08-04       Impact factor: 3.584

2.  A new in situ brain perfusion flow correction method for lipophilic drugs based on the pH-dependent Crone-Renkin equation.

Authors:  Alex Avdeef; Na Sun
Journal:  Pharm Res       Date:  2010-11-02       Impact factor: 4.200

3.  Improved measurement of drug exposure in the brain using drug-specific correction for residual blood.

Authors:  Markus Fridén; Helena Ljungqvist; Brian Middleton; Ulf Bredberg; Margareta Hammarlund-Udenaes
Journal:  J Cereb Blood Flow Metab       Date:  2009-09-16       Impact factor: 6.200

4.  Cyclodextrin alleviates neuronal storage of cholesterol in Niemann-Pick C disease without evidence of detectable blood-brain barrier permeability.

Authors:  Charles C Pontikis; Cristin D Davidson; Steven U Walkley; Frances M Platt; David J Begley
Journal:  J Inherit Metab Dis       Date:  2013-02-15       Impact factor: 4.982

5.  Quantitative Fluorescence Microscopy Measures Vascular Pore Size in Primary and Metastatic Brain Tumors.

Authors:  Rajendar K Mittapalli; Chris E Adkins; Kaci A Bohn; Afroz S Mohammad; Julie A Lockman; Paul R Lockman
Journal:  Cancer Res       Date:  2016-11-04       Impact factor: 12.701

6.  Uptake of ANG1005, a novel paclitaxel derivative, through the blood-brain barrier into brain and experimental brain metastases of breast cancer.

Authors:  Fancy C Thomas; Kunal Taskar; Vinay Rudraraju; Satyanarayana Goda; Helen R Thorsheim; Julie A Gaasch; Rajendar K Mittapalli; Diane Palmieri; Patricia S Steeg; Paul R Lockman; Quentin R Smith
Journal:  Pharm Res       Date:  2009-09-23       Impact factor: 4.200

Review 7.  Elimination of substances from the brain parenchyma: efflux via perivascular pathways and via the blood-brain barrier.

Authors:  Stephen B Hladky; Margery A Barrand
Journal:  Fluids Barriers CNS       Date:  2018-10-19

Review 8.  On the rate and extent of drug delivery to the brain.

Authors:  Margareta Hammarlund-Udenaes; Markus Fridén; Stina Syvänen; Anubha Gupta
Journal:  Pharm Res       Date:  2007-12-05       Impact factor: 4.200

9.  Population pharmacokinetic approach for evaluation of treosulfan and its active monoepoxide disposition in plasma and brain on the basis of a rat model.

Authors:  Dorota Danielak; Michał Romański; Anna Kasprzyk; Artur Teżyk; Franciszek Główka
Journal:  Pharmacol Rep       Date:  2020-05-30       Impact factor: 3.024

Review 10.  Emerging insights into barriers to effective brain tumor therapeutics.

Authors:  Graeme F Woodworth; Gavin P Dunn; Elizabeth A Nance; Justin Hanes; Henry Brem
Journal:  Front Oncol       Date:  2014-07-21       Impact factor: 6.244

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.